CN102406780B - Traditional Chinese medicine composition used for drug abstinence - Google Patents
Traditional Chinese medicine composition used for drug abstinence Download PDFInfo
- Publication number
- CN102406780B CN102406780B CN2011103729679A CN201110372967A CN102406780B CN 102406780 B CN102406780 B CN 102406780B CN 2011103729679 A CN2011103729679 A CN 2011103729679A CN 201110372967 A CN201110372967 A CN 201110372967A CN 102406780 B CN102406780 B CN 102406780B
- Authority
- CN
- China
- Prior art keywords
- kilograms
- chinese medicine
- drug
- rhizoma
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 48
- 229940079593 drug Drugs 0.000 title claims abstract description 28
- 239000000203 mixture Substances 0.000 title claims abstract description 12
- 241000218176 Corydalis Species 0.000 claims abstract description 5
- 241000545442 Radix Species 0.000 claims description 6
- 241000903946 Clematidis Species 0.000 claims description 4
- 241000237636 Pheretima Species 0.000 claims description 4
- 241000522620 Scorpio Species 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 240000001972 Gardenia jasminoides Species 0.000 claims 1
- 208000011117 substance-related disease Diseases 0.000 abstract description 12
- 206010013663 drug dependence Diseases 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 6
- 239000009636 Huang Qi Substances 0.000 abstract description 2
- 241000173529 Aconitum napellus Species 0.000 abstract 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000218158 Clematis Species 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 244000111489 Gardenia augusta Species 0.000 abstract 1
- 241000146384 Glaux Species 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 241000243684 Lumbricus Species 0.000 abstract 1
- 240000005373 Panax quinquefolius Species 0.000 abstract 1
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract 1
- 241001522129 Pinellia Species 0.000 abstract 1
- 241000239226 Scorpiones Species 0.000 abstract 1
- 241001300193 Speranskia Species 0.000 abstract 1
- 241000746716 Typhonium Species 0.000 abstract 1
- 241000157352 Uncaria Species 0.000 abstract 1
- 229940023019 aconite Drugs 0.000 abstract 1
- 235000021028 berry Nutrition 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 230000006870 function Effects 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 8
- 206010013654 Drug abuse Diseases 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 206010012335 Dependence Diseases 0.000 description 4
- GVGLGOZIDCSQPN-PVHGPHFFSA-N Heroin Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4OC(C)=O GVGLGOZIDCSQPN-PVHGPHFFSA-N 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 229960002069 diamorphine Drugs 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 231100000167 toxic agent Toxicity 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 206010013754 Drug withdrawal syndrome Diseases 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 239000007963 capsule composition Substances 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 208000030507 AIDS Diseases 0.000 description 2
- 241000157835 Gardenia Species 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 235000019788 craving Nutrition 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical group [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 229960002532 methamphetamine hydrochloride Drugs 0.000 description 1
- TWXDDNPPQUTEOV-FVGYRXGTSA-N methamphetamine hydrochloride Chemical compound Cl.CN[C@@H](C)CC1=CC=CC=C1 TWXDDNPPQUTEOV-FVGYRXGTSA-N 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 239000004081 narcotic agent Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 229940127240 opiate Drugs 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000000506 psychotropic effect Effects 0.000 description 1
- 239000009490 scorpio Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a traditional Chinese medicine composition used for drug abstinence, which is composed of the following traditional Chinese medicine bulk drugs: 15-35kg of American ginseng, 15-35kg of maggot, 15-35kg of smallflower milkwort herb with root, 15-35kg of Chinese teasel root, 15-35kg of Radix Astragali, 15-35kg of shizandra berry, 15-35kg of Giant typhonium rhizome, 15-35kg of rhizoma atractylodis alba, 15-35kg of clematis root , 15-35kg of speranskia herb, 15-35kg of Rhizoma Corydalis, 6-12kg of herba asaricum radice, 15-35kg of dahurian angelica, 15-35kg of lumbricus, 15-35kg of gardenia, 15-35kg of Scorpion, 15-35kg of rhizoma ligustici wallichii, 15-35kg of uncaria, 6-12kg of processed monkshood, 6-12kg of processed wild aconite, 15-35kg of processed pinellia ternate and 15-35kg of licorice. The traditional Chinese medicine composition used for drug abstinence has the advantages that the drug addicts enable complete withdrawal on drug addiction, readdiction of drugs will not generated, the curative effect is fast, the treatment course is short, and no toxic and side effects is generated.
Description
Technical field
The present invention relates to a kind of drug-relief medicine, specifically, relate to a kind of drug rehabilitation Chinese medicine composition.
Background technology
Drugs are public enemies of the people of the world, and it not only brings out crime, destroy normal society and economic order, influence social stability, cause the massive losses and the waste of the wealth of society, and also human beings'health, survival and development in serious threat.For find a kind of effectively and the drug rehabilitation method of science, international, domestic many pharmacy, medical science man and drug rehabilitation expert have carried out extensive and deep research to the mechanism of action of drugs, some progress have been obtained, but with regard to drug abstinence, relapse rate is still high, is perplexing international community.
The existing anti-additive medicament that has gone on the market both at home and abroad is narcotics or psychotropic substances basically, starting point and the purpose of using these medicines to quit drug abuse are in order to control or alleviate the misery of patient's withdrawal symptom, only play and press addiction, analgesia, anaesthetize, sleep peacefully, hazy and illusionary or alternate effect, still can't give up the heart addiction of junkie.
Summary of the invention
The object of the present invention is to provide a kind of heart addiction of eliminating junkie, drug abstinence is good, the drug rehabilitation Chinese medicine composition that relapse rate is low.
Technical scheme of the present invention is, a kind of drug rehabilitation Chinese medicine composition is made up of following raw material of Chinese medicine medicine: 15-35 kilograms of Radix Panacis Quinquefoliis, 15-35 kilograms of Chrysomyiame gacephala (Fab.), 15-35 kilograms of Herba Polygalae Telephioidis, 15-35 kilograms of Radix Et Rhizoma Rhei, 15-35 kilograms of the Radixs Astragali, 15-35 kilograms of Fructus Schisandrae Chinensis, 15-35 kilograms of Radix Aconiti Lateralis Preparata, 15-35 kilograms of the Rhizoma Atractylodis Macrocephalaes, 15-35 kilograms of Radix Clematidis, 15-35 kilograms of Herba speranskiae tuberculataes, 15-35 kilograms of Rhizoma Corydalis (processed)s, 6-12 kilograms of Herba Asaris, 15-35 kilograms of the Radixs Angelicae Dahuricae, 15-35 kilograms of Pheretimas, 15-35 kilograms of Fructus Gardeniaes, 15-35 kilograms of Scorpios, 15-35 kilograms of Rhizoma Chuanxiongs, 15-35 kilograms of Ramulus Uncariae Cum Uncis, 6-12 kilograms of Radix Aconiti Preparatas, 6-12 kilograms of Radix Aconiti Kusnezoffii Preparatas, 15-35 kilograms of Rhizoma Pinelliae Preparata, 15-35 kilograms in Radix Glycyrrhizae.
The principles of formulating prescriptions:
In the side, Radix Panacis Quinquefolii, the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Fructus Schisandrae Chinensis have invigorating QI and blood, spleen benefiting and stimulating the appetite, tranquillizing and allaying excitement, recovery organization function; Scorpio, Radix Aconiti Preparata, Radix Aconiti Kusnezoffii Preparata, Fructus Gardeniae, Radix Glycyrrhizae, Radix Et Rhizoma Rhei have relieving constipation, detoxication and toxicant eliminating function function, Rhizoma Pinelliae Preparata eliminate the phlegm heresy, eliminating dampness by diuresis effect; Radix Clematidis, Herba speranskiae tuberculatae, Rhizoma Corydalis (processed), Pheretima, Herba Asari, the Radix Angelicae Dahuricae, Rhizoma Chuanxiong, Ramulus Uncariae Cum Uncis have blood circulation promoting and blood stasis dispelling, Shujin, dispel the wind, relieving convulsion, pain-relieving functions; The Radix Aconiti Lateralis Preparata warming and recuperating the kidney-YANG; Above medicine is gold conjugate timothy, Chrysomyiame gacephala (Fab.) etc. again, full side has effects such as invigorating QI and blood body fluid, detoxication and toxicant eliminating function, tranquillizing and allaying excitement, blood circulation promoting and blood stasis dispelling, recovery organization function, mediator's yin-yang, can effectively eliminate acute withdrawal symptom and protracted abstinence symptom (psa), the patient is finished from physiology and the psychological dependence of thoroughly eliminating drugs simultaneously synchronously.
Preparation method:
The example that is prepared as with capsule formulation: the preparation method of capsule formulation routinely, above medicine is got the raw materials ready by weight, through cleaning, oven dry, pulverize, mix homogeneously, in incapsulating, each capsules is adorned a gram medicated powder.
Instructions of taking: obey every day three times, obey six at every turn, took medicine continuously 10 days, ante cibum warm water delivery service.
Function cures mainly: invigorating QI and blood body fluid, detoxication and toxicant eliminating function, blood circulation promoting and blood stasis dispelling, rebuild one's physical constitution, function such as mediator's yin-yang.
Indication: be used for the treatment of drug dependence and drug dependence (heart addiction) that opiates (heroin, morphine) and novel drug materials such as (methamphetamine hydrochloride, k powder, head-shaking pill) causes.
The present invention quits drug abuse and uses Chinese medicine composition, system is according to the Chinese medical discrimination analysis, the drug abuse patient belongs to deficiency of both YIN and YANG, the impaired clinical manifestation of qi-blood-body fluid more, it is main that first-selection helps the deficiency of YIN, the deficiency of vital energy and invigorating QI and blood body fluid for tens of kinds, cooperate medicines such as detoxication and toxicant eliminating function, blood circulation promoting and blood stasis dispelling, tranquillizing and allaying excitement again and prescription develops.
Use Chinese medicine composition of the present invention to quit drug abuse, junkie not only can be given up drug addiction fully, and can not revert to take drugs again, makes it to become physical and mental health, self-supporting, the law-abiding citizen useful to society.And curative effect is fast, short treating period, have no side effect.
The specific embodiment
Below in conjunction with embodiment the present invention is described in further detail.
Embodiment 1
Prescription: 15 kilograms of Radix Panacis Quinquefoliis, 15 kilograms of Chrysomyiame gacephala (Fab.), 15 kilograms of Herba Polygalae Telephioidis, 15 kilograms of Radix Et Rhizoma Rhei, 15 kilograms of the Radixs Astragali, 15 kilograms of Fructus Schisandrae Chinensis, 15 kilograms of Radix Aconiti Lateralis Preparata, 15 kilograms of the Rhizoma Atractylodis Macrocephalaes, 15 kilograms of Radix Clematidis, 15 kilograms of Herba speranskiae tuberculataes, 15 kilograms of Rhizoma Corydalis (processed)s, 6 kilograms of Herba Asaris, 15 kilograms of the Radixs Angelicae Dahuricae, 15 kilograms of Pheretimas, 15 kilograms of Fructus Gardeniaes, 15 kilograms of Scorpios, 15 kilograms of Rhizoma Chuanxiongs, 15 kilograms of Ramulus Uncariae Cum Uncis, 6 kilograms of Radix Aconiti Preparatas, 6 kilograms of Radix Aconiti Kusnezoffii Preparatas, 15 kilograms of Rhizoma Pinelliae Preparata, 15 kilograms in Radix Glycyrrhizae.
Preparation: the preparation method of capsule formulation routinely, get the raw materials ready by above drug weight ratio, through cleaning, oven dry, pulverize, mix homogeneously, in incapsulating, each capsules is adorned a gram medicated powder.
Drug abstinence is observed:
1, the object of observation
1.1 this clinical observation is totally 7 examples, 36 years old mean age.Heroin addict 5 examples, heroin are mixed dependent's 2 examples with novel drug.
1.2 all drug abuse patients that accept test this time all adopt voluntary principle, all meet the diagnostic criteria that DSM-4 heroin relies on and novel drug relies on.
1.3 the object of observation is selected no great body illness, acquired immune deficiency syndrome (AIDS) and drug sensitivity disease etc.
2, method
2.1 before patient's begin treatment, know the inside story and agree to use embodiment 1 product voluntarily.
2.2 the doctor carries out comprehensive physical examination to the patient who observes before treating, and understands history of drug abuse and present symptom.
All right coffee detects 2.3 begin treatment advances, and positive person can carry out this drug addiction treatment.
2.4 the doctor records faithfully the situation of taking at every turn, and situation is filled in the observation table every day according to the observation.
2.5 instructions of taking.
2.5.1 begin to take after urine examination and the health check-up for the first time, each 6, took once every 4 hours later on, totally 3 times at every turn, took continuously 8 days, observed the totally 10 days course of treatment 2 days.
2.5.2 all under staff's supervision, take at every turn.
2.5.3 what reaction is arranged after taking, has the doctor to record faithfully.
Two, clinical observation result
Use during the embodiment 1 product drug addiction treatment, any untoward reaction does not appear in the patient, serious withdrawal symptom do not occur, is emotionally stable after the patient takes, and it is fine to sleep, and realizes clearly, and appetite is normal; Began urine rare increase by twice of repeatedly defecating on the 2nd day, sleep, appetite are good, and urine detection was negative in the 6th day; Of pink and healthy-looking after the 7th day, be in a cheerful frame of mind, like movable, the mental status is all the same with the normal person, and body weight obviously increases, and drugs are not in the mood for craving for.Detect liver function, renal function, electrocardiogram during end, there is no unusual.
Claims (1)
1. drug rehabilitation Chinese medicine composition, its characteristic is, is made up of following raw material of Chinese medicine medicine: 15 kilograms of Radix Panacis Quinquefoliis, 15 kilograms of Chrysomyiame gacephala (Fab.), 15 kilograms of Herba Polygalae Telephioidis, 15 kilograms of Radix Et Rhizoma Rhei, 15 kilograms of the Radixs Astragali, 15 kilograms of Fructus Schisandrae Chinensis, 15 kilograms of Radix Aconiti Lateralis Preparata, 15 kilograms of the Rhizoma Atractylodis Macrocephalaes, 15 kilograms of Radix Clematidis, 15 kilograms of Herba speranskiae tuberculataes, 15 kilograms of Rhizoma Corydalis (processed)s, 6 kilograms of Herba Asaris, 15 kilograms of the Radixs Angelicae Dahuricae, 15 kilograms of Pheretimas, 15 kilograms of Fructus Gardeniaes, 15 kilograms of Scorpios, 15 kilograms of Rhizoma Chuanxiongs, 15 kilograms of Ramulus Uncariae Cum Uncis, 6 kilograms of Radix Aconiti Preparatas, 6 kilograms of Radix Aconiti Kusnezoffii Preparatas, 15 kilograms of Rhizoma Pinelliae Preparata, 15 kilograms in Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011103729679A CN102406780B (en) | 2011-11-22 | 2011-11-22 | Traditional Chinese medicine composition used for drug abstinence |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011103729679A CN102406780B (en) | 2011-11-22 | 2011-11-22 | Traditional Chinese medicine composition used for drug abstinence |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102406780A CN102406780A (en) | 2012-04-11 |
| CN102406780B true CN102406780B (en) | 2013-07-31 |
Family
ID=45909317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011103729679A Expired - Fee Related CN102406780B (en) | 2011-11-22 | 2011-11-22 | Traditional Chinese medicine composition used for drug abstinence |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102406780B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108272942A (en) * | 2018-03-08 | 2018-07-13 | 王科亮 | A kind of Chinese medicine composition and its preparation method and application for drug rehabilitation |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1179320A (en) * | 1997-08-13 | 1998-04-22 | 夏小林 | Narcotic Chinese medicine |
| CN1471954A (en) * | 2003-06-27 | 2004-02-04 | 熊治成 | Chinese medicine for withdrawal of drug dependence |
| CN1621080A (en) * | 2003-11-28 | 2005-06-01 | 罗建会 | Medicine for abstaining from drug addiction and its preparation |
| CN102038706A (en) * | 2009-10-19 | 2011-05-04 | 深圳市源柏菲中医药开发有限公司 | Drug treatment and rehabilitation Chinese herbal composition |
| CN102114195A (en) * | 2011-03-01 | 2011-07-06 | 陈都 | Anti-drug capsule prepared from pure traditional Chinese medicines |
-
2011
- 2011-11-22 CN CN2011103729679A patent/CN102406780B/en not_active Expired - Fee Related
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1179320A (en) * | 1997-08-13 | 1998-04-22 | 夏小林 | Narcotic Chinese medicine |
| CN1471954A (en) * | 2003-06-27 | 2004-02-04 | 熊治成 | Chinese medicine for withdrawal of drug dependence |
| CN1621080A (en) * | 2003-11-28 | 2005-06-01 | 罗建会 | Medicine for abstaining from drug addiction and its preparation |
| CN102038706A (en) * | 2009-10-19 | 2011-05-04 | 深圳市源柏菲中医药开发有限公司 | Drug treatment and rehabilitation Chinese herbal composition |
| CN102114195A (en) * | 2011-03-01 | 2011-07-06 | 陈都 | Anti-drug capsule prepared from pure traditional Chinese medicines |
Non-Patent Citations (4)
| Title |
|---|
| 《中医药戒毒研究概况》;周祖文;《 内蒙古中医药》;20030331(第2003-03期);第32-34页 * |
| 《中医药戒毒研究进展》;王瑾,张秀菊,赵志玲;《解放军药学学》;20010630;第17卷(第3期);第145-147页 * |
| 周祖文.《中医药戒毒研究概况》.《 内蒙古中医药》.2003,(第2003-03期),第32-34页. |
| 王瑾,张秀菊,赵志玲.《中医药戒毒研究进展》.《解放军药学学》.2001,第17卷(第3期),第145-147页. |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102406780A (en) | 2012-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103550532B (en) | Traditional Chinese medicine (TCM) composition for treating palpitation | |
| CN102133271B (en) | Medicinal tea for curing gout | |
| CN101972386A (en) | Traditional Chinese medicine for treating diabetic gout | |
| CN102114195B (en) | Anti-drug capsule prepared from pure traditional Chinese medicines | |
| CN101199796B (en) | External antidiarrhoeal medicament, preparing method and function thereof | |
| CN104288496A (en) | Traditional Chinese medicine composition for treating constipation | |
| CN102018852B (en) | Ginseng and coptis capsule for quenching thirsty and reducing blood sugar and preparation process | |
| CN102406780B (en) | Traditional Chinese medicine composition used for drug abstinence | |
| CN103356932B (en) | A kind of pharmaceutical composition for the treatment of vulva squamous epithelial hyperplasia | |
| CN101912540A (en) | Medicament for treating cerebral infarction | |
| CN100394976C (en) | Chinese medicine for withdrawal of drug dependence | |
| CN101961448A (en) | Chinese medicament for treating diabetic gout | |
| CN102861289B (en) | Chinese medicinal drug addiction stopping and three-hyper lowering capsule | |
| CN110251568A (en) | A kind of Chinese medicine compound prescription and preparation method thereof for treating leucoderma | |
| CN108686094A (en) | A kind of Traditional Chinese medicine for decreasing blood sugar and preparation method thereof | |
| CN103385998A (en) | Traditional Chinese medicine preparation used for treating infantile dysentery | |
| CN101966279A (en) | Traditional Chinese medicine for treating diabetic gout | |
| CN101966304A (en) | Medicament for freeing network vessels and activating blood and preparation method thereof | |
| CN102274291A (en) | Chinese medicinal preparation for treating stroke and production method thereof | |
| CN102114225A (en) | Traditional Chinese medicine for treating gout of diabetes patient | |
| CN1250274C (en) | Medicine for abstinence of drugs and rehabilitation, and preparing process thereof | |
| CN104606596A (en) | Chinese patent medicine for treating behcet disease and preparation method of Chinese patent medicine | |
| CN103520588A (en) | A Chinese herbal medicine composition used for drug rehabilitation | |
| CN104161990A (en) | Traditional Chinese medicine composition for treating cardiopalmus | |
| CN101966280A (en) | Traditional Chinese medicine for treating diabetes mellitus and gout |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Wu Yuguang Inventor after: Li Jianwen Inventor before: Wu Yuguang Inventor before: Chen Rihong Inventor before: Zheng Zhuo |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WU YUGUANG CHEN RIHONG ZHENG ZHUO TO: WU YUGUANG LI JIANWEN |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: ANSHUN NEW CENTURY SUNSHINE TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: WU YUGUANG Effective date: 20140313 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 417600 LOUDI, HUNAN PROVINCE TO: 561000 ANSHUN, GUIZHOU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20140313 Address after: 561000 Guizhou province Xixiu District of Anshun City East Road No. 8 Patentee after: Anshun New Century Sunshine Technology Co., Ltd. Address before: 417600 No. 318, Gucheng Road, Shang Mei Town, Xinhua County, Hunan Patentee before: Wu Yuguang |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20170814 Address after: 518000 Guangdong city of Shenzhen province Futian District four Zhuzilin Shichiku six interchange with the more sea homes 3 8G (office only) Patentee after: Shenzhen Daying Information Consulting Co., Ltd. Address before: 561000 Guizhou province Xixiu District of Anshun City East Road No. 8 Patentee before: Anshun New Century Sunshine Technology Co., Ltd. |
|
| TR01 | Transfer of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130731 Termination date: 20181122 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |